Key Takeaways
Option Care Health (NASDAQ: OPCH) shares plunged 24% after the company lowered its 2026 revenue forecast, prompting an investigation by law firm Kirby McInerney LLP into potential securities law violations.
"The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices," Kirby McInerney LLP said in a statement announcing the inquiry.
The healthcare services provider cut its full-year revenue guidance to a range of $5.675 billion to $5.775 billion, down from a prior forecast of $5.8 billion to $6.0 billion provided just two months earlier. The company blamed the downward revision on “lower CID patient retention and therapy mix.” The news sent shares plummeting from $26.87 to close at $20.33 on April 30.
The sharp reversal in guidance has put management's credibility in question. On the fourth-quarter 2025 earnings call on February 24, CEO John Rademacher had expressed confidence in the initial, higher guidance. The first-quarter 2026 results, which accompanied the guidance cut, showed revenue of $1.35 billion, missing consensus estimates, and a 3.0% year-over-year decline in net income to $45.3 million.
The stock's 24% decline has erased significant market value, reflecting investor concern over the sudden change in the company's outlook. The investigation by Kirby McInerney adds a layer of legal and financial risk, with potential for a class-action lawsuit. Investors will be closely watching for any formal legal filings and the company's response to the allegations.
This article is for informational purposes only and does not constitute investment advice.
